01 1Biocon
01 1DEFERASIROX
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2015-04-06
Pay. Date : 2014-12-08
DMF Number : 28626
Submission : 2015-01-02
Status : Active
Type : II
20
Biocon Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is DEFERASIROX, with a corresponding US DMF Number 28626.
Remarkably, this DMF maintains an Active status since its submission on January 02, 2015, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 06, 2015, and payment made on December 08, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II
